Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bigfoot Biomedical Closes $55M Series C Financing, Plans FDA Filing For Diabetes System

03 Jun 2020

• By Marion Webb

Diabetes

Related Content

Market Intel: Bigfoot Biomedical, Beta Bionics Getting Pumped To Introduce Next-Gen Artificial Pancreas

18 Dec 2019

Market Intel: After A Year Of Partnerships, Insulin Pump Manufacturers Will Face Fierce Competition In 2020

09 Dec 2019

Related Companies

Bigfoot Biomedical, Inc.

Abbott

Additional Topics

Financing Coronavirus COVID-19 Platform Technologies Digital Health FDA Innovation Commercial Diabetic Care Medical Device

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.